Skip to main content
Fig. 3 | World Allergy Organization Journal

Fig. 3

From: Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

Fig. 3

Percentage of (a) controlled (ACQ < 4) and (b) fully controlled patients (ACQ < 1) in the worst and best scenarios. Best scenario: Patients with missing ACQ total scores were considered "controlled" if ACQ scores were <4 in any one assessment, and patients were not dropped out owing to efficacy. Worst scenario: Patients with missing ACQ total scores at 6 or 12 months follow-up visits were considered "not controlled".  *Responders were patients who achieved asthma control (ACQ < 4) at both 6 and 12 months. ACQ, Asthma Control Questionnaire

Back to article page

World Allergy Organization Journal

ISSN: 1939-4551

Contact us